Epidarex Capital
Founded 2010
About Epidarex Capital
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, international corporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Company Facts
- Founded: 2010
- Legal name: Epidarex Capital Partners LLC
- Operating status: Operating
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Website: epidarex.com
- Phone: 301 298 5455
Social Profiles
Canonical: https://fsome.com/organization/epidarex-capital-8366335 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.